Lantheus Holdings, Inc. (LNTH) Stock Forecast & Price Target
Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Lantheus Holdings, Inc. (LNTH), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Lantheus Holdings, Inc., analysts forecast revenue rising from $1.50B in 2025 to $2.44B in 2030; the average estimate for 2030 earnings per share is $9.87; with published estimates ranging from $9.24 to $10.78; 11 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Lantheus Holdings, Inc. (LNTH) forecast — frequently asked questions
What is the analyst price target for Lantheus Holdings, Inc.?
Analysts covering Lantheus Holdings, Inc. (LNTH) have a consensus price target of $104.38, 2.6% above the current price of $101.76. Published targets range from $102.50 to $109.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Lantheus Holdings, Inc.'s earnings?
The average analyst estimate for Lantheus Holdings, Inc. (LNTH) earnings per share in 2030 is 9.87, with individual estimates between 9.24 and 10.78.
How much revenue is Lantheus Holdings, Inc. expected to make?
Analysts forecast Lantheus Holdings, Inc. (LNTH) revenue of $2.44B in 2030, based on 5 published estimates.
How many analysts cover LNTH?
11 analysts contribute estimates for Lantheus Holdings, Inc. (LNTH). Thin coverage makes an average less reliable.
Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.